Clinical

BDD have offered a range of clinical services to the pharmaceutical industry and biotech industries for over 20 years.

Phase I Clinical Trials

The first step in evaluating the safety, tolerability, and pharmacokinetics of investigational drugs in human subjects.

Propellant Studies

Propellant Testing using Mucociliary Clearance (MCC)
Proven expertise in clinical evaluation of novel pMDI propellants.

Adaptive Clinical Trials

Propellant Testing using Mucociliary Clearance (MCC)

Proven expertise in clinical evaluation of novel pMDI propellants.

Gamma Scintigraphy

A versatile, non-invasive, imaging technique which offers early-stage evaluation of drug delivery systems in vivo, in real time.